Influence of ACTH-(1-24) and plasma hyperviscosity on free radical production and capillary perfusion after hemorrhagic shock

Microcirculation

Volumn 11, Issue 3, 2004, Pages 227-238

  Bertuglia, S ^a   Giusti, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

ACTH (1 24); Hemorrhagic shock; Leukocytes; Microcirculation; Oxygen free radicals; Plasma viscosity

Indexed keywords

DEXTRAN; FREE RADICAL; LIPID PEROXIDASE; N(G) METHYLARGININE; NITROUS OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TETRACOSACTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; ATTENUATION; BIOASSAY; BLOOD FLOWMETRY; CAPILLARY FLOW; CHEEK POUCH; CONTROLLED STUDY; DRUG MECHANISM; ERYTHROCYTE; HAMSTER; HEMORRHAGIC SHOCK; INJECTION; LEUKOCYTE ADHERENCE; MALE; MEAN ARTERIAL PRESSURE; MICROVASCULARIZATION; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE STRESS; PLASMA VISCOSITY; PRIORITY JOURNAL; PROTECTION; RESUSCITATION; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM; VASODILATATION; VELOCITY;

ANIMALS; BLOOD PRESSURE; BLOOD VISCOSITY; CAPILLARIES; COSYNTROPIN; CRICETINAE; FREE RADICALS; LEUKOCYTES; MALE; MESOCRICETUS; OXIDATIVE STRESS; PERFUSION; PROTECTIVE AGENTS; SHOCK, HEMORRHAGIC; VASODILATION;

ANIMALIA; CRICETINAE;

EID: 10244220967     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1080/10739680490425930     Document Type: Article

References (44)

1. Altavilla D, Saitta A, Guarini S, Galeano M, Squadrito G, Santamaria LB, Venuti FS, Bazzani C, Bertolini A, Squadrito F. (2001). Nuclear factor-kappaB as a target of cyclosporin in acute hypovolemic hemorrhagic shock. Cardiovasc Res 52:143-152.
2. Barroso-Aranda J, Zweifach BW, Mathison JC, Schmid-Schönbein GW. (1995). Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock. Cardiovasc Pharmacol 25:S23-S29.
3. Bauer C, Walcher F, Holanda M, Mertzlufft F, Larsen R, Marzi I. (2002). Antioxidative resuscitation solution prevents leukocyte adhesion in the liver after hemorrhagic shock. J Trauma 46:886-893.
4. Bazzani C, Mioni C, Ferrazza G, Cainazzo MM, Bertolini A, Guarini S. (2002). Involvement of the central nervous system in the protective effect of melanocortins in myocardial ischaemia/reperfusion injury. Resuscitation 52:109-115.
5. Beckman JS, Beckman TW, Chen J, Marshal PA, Freeman BA. (1990). Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624.
6. Behrman SW, Fabian TC, Kudsk KA, Proctor KG. (1991). Microcirculatory flow changes after initial resuscitation of hemorrhagic shock with 7.5% hypertonic saline/dextran 70. J Trauma 31:589-594.
7. Bertuglia S, Colantuoni A. (1997). Venular oscillatory flow during hemorrhagic shock and NO inhibition in hamster cheek pouch. Microvasc Res 54:233-242.
8. Bertuglia S. (2001). Increased viscosity is protective for microvascular perfusion during severe hemodilution in hamster cheek pouch. Microvasc Res 61:56-63.
9. Bertuglia S, Giusti A, Fedele S, Picano E. (2001). Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischemia-reperfusion-induced damage. Diabetologia 44:2165-2170.
10. Bertuglia S, Giusti A. (2002). Blockade of P-selectin does not affect reperfusion injury in hamsters subjected to GSH inhibition. Microvasc Res 64:56-64.
11. Bertuglia S, Giusti A, Pittman RN. (2002). Microcirculatory oxygenation and oxygen free radical generation during ischemia and reperfusion. J Vasc Res 39:32.
12. Brown JM, Grosso MA, Moore EE. (1990). Hypertonic saline dextran. Impact on cardiac function in the isolated rat heart. J Trauma 30:646-652.
13. Brown LP, Williams RL, Mckirnan MD, Limjoco UR, Gray CG. (1995). Nitric oxide synthesis inhibition does not improve the hemodynamic response to hemorrhagic shock in dehydrated conscious swine. Shock 3:292-298.
14. Cesarone MR, Incandela L, DeSanctis MT, Belcaro G, Dugall M, Acerbi G. (2002). Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trial. J Cardiovasc Pharmacol Ther 7:S25-S28.
15. Chen RY, Carlin RD, Simchon S, Jan KM, Chien S. (1989). Effects of dextran-induced hyperviscosity on regional blood flow and hemodynamics in dogs. Am J Physiol 256:H989-H905.
16. Crown JP, Beckman JS. (1995). The role of peroxynitrite in nitric oxide-mediated toxicity. Curr Top Microbiol Immunol 196:57-73.
17. Deitch EA, Bridges W, Berg R, Specian RD, Granger DN. (1990). Hemorrhagic shock induces bacterial translocation: the role of neuthrophils and hydroxyl radicals. J Trauma 30:942-951.
18. Fisher AB, Al-Mehdi AB, Wei Z, Song C, Manevich Y. (2003). Lung ischemia: endothelial cell signaling by reactive oxygen species. A Progress report. Adv Exp Med Biol 510:343-347.
19. Fructerman TM, Spain DA, Matheson PJ. (1998). Small intestinal production of nitric oxide is decreased following resuscitated hemorrhage. J Surg Res 80:102-109.
20. Getting SJ. (2002). Melanocortin peptides and their receptors new targets for anti-inflammatory therapy. Trends Pharmacol Sci 23:447-449.
21. Granger DN, Kortius RJ. (1995). Physiologycal mechanism of postichemic tissue injury. Annu Rev Physiol 57:311-313.
22. Guarini S, Bazzani C, Cainazzo MM, Mioni C, Mioni C, Ferrazza G, Vergoni AV, Schioth HB, Wikberg JE, Bertolini A. (1999). Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides. Pharmacol Exp Therap 291:1023-1027.
23. Heckbert SR, Vedder NB, Hoffman W, Winn RK, Hudson LD, Jurkovich GJ, Copass MK, Harlan JM, Rice CL, Maier RV. (1998). Outcome after hemorrhagic shock in trauma patients. J Trauma 45:545-549.
24. Hein LG, Albrecht DM, Dworschak M, Frey L, Bruckner UB. (1998). Long observation following traumatic hemorrhagic shock in the dog: a comparison of crystalloidal vs. colloidal fluids. Circ Shock 26:353-364.
25. Hol EM, Gispen WH, Bar PR. (1995). ACTH-related peptides: receptors and signal transduction systems involved in their neurotrophic and neuroprotective actions. Peptides 16:979-993.
26. Intaglietta M. (1997). Whitaker Lecture 1996: Microcirculation, Biomedical Engineering and Artificial Blood. Ann Biomed Eng 25:593-603.
27. Jarrar D, Wang P, Knoferl MW, Cioffi WG, Bland KI, Chaudry IH. (2000). Does early infusion of red blood cells after trauma and hemorrhage improve organ functions? Crit Care Med 28:3498-3504.
28. Kashiwagi S, Kajimura M, Yoshimura Y, Suematsu M. (2002). Nonendothelial source of nitric oxide in arterioles but not in venules: alternative source revealed in vivo by diaminofluorescein microfluorography. Circ Res 13, 91:e55-e64.
29. Krieter H, Brückner UB, Kafalianakis F, Messmer K. (1995). Does colloid induced plasma hyperviscosity in haemodilution jeopardize perfusion and oxygenation of vital organs? Acta Anaest Scand 39:326-344.
30. Kroemer H, Haass A, Muller K, Jager H, Wagner EM, Heimburg P, Klotz U. (1987). Hemodilution therapy in ischemic stroke. Plasma concentration and plasma viscosity during long term infusion of dextran 40 or hydroxyethly starch 200/0.5. Eur J Clin Pharmacol 31:705-710.
31. Kunchan MJH, Frangos, JA. (1998). Role of G protein in shear stress mediated nitric oxide production by endothelial cells. Am J Physiol 254:H331-H338.
32. Menezes JM, Hierholzer C, Watkins SC, Billiar TR, Peitzman AB, Harbrecht BG. (2002). The modulation of hepatic injury and heat shock expression by inhibition of inducible nitric oxide synthase after hemorrhagic shock. Shock 17:13-18.
33. Moncada S, Palmer RMJ, Higgs EA. (1991). Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-112.
34. Moss GS, Rise CL. (1998). Advantages and disadvantages of rapid colloid resuscitation. In the Role of Hemodilution in Optimal Patient Care (Tuma RF, White JV, and Messmer K, Eds). München: Zuckschwerdt, 54-74.
35. Noera G, Lamarra M, Guarini S, Bertolini A. (2001). Survival after early treatment for acute type-aortic dissection with ACTH-(1-24). Lancet 358:469-470.
36. Radi R, Rodriguez M, Castro L, Telleri R. (1994). Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308:89-95.
37. Scalia SV, Taheri PA, Force S, Ozmen V, Lui D, Fish J, Hansen D, Chambers R, Flint L, Steinberg S. (1992). Mesenteric microcirculatory changes in non-lethal hemorrhagic shock, the role of resuscitation with balanced electrolyte or hypertonic saline/dextran. Br J Trauma 33:321-328.
38. Squadrito F, Guarini S, Altavilla D, Campo GM, Arlotta M, Quartarone C, Saitta A, Cucinotta D, Bazzani C, Cainazzo MM, Mioni C, Bertolini A, Caputi AP. (1999). Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock. Br J Pharmacol 128:816-822.
39. Szabo C, Thiemermann C. (1994). Role of nitric oxide in hemorrhagic, traumatic and anaphylactic shock and in thermal injury. Shock 2:145-155.
40. Versteeg DHG, Van Berger P, Adan RA, De Wildt DJ. (1998). Melanocortins and cardiovascular regulation. Eur J Pharmacol 360:1-14.
41. Van Bergen P, Van Der Vaart JGM, Kasbegen CM, Versteeg DH, De Wildt DJ. (1996). Structure activity analysis for the effects of α-MSH/ACTH-like peptides on cerebral hemodynamics in rats. Eur J Pharmacol 318:357-368.
42. Wang P, Ba Z, Biondo A, Chaudry I. (1996). Liver endothelial cell dysfunction occurs early after hemorrhagic shock and persists despite crystalloide resuscitation. J Surg Res 63:241-248.
43. Wilkstrom T, Braide M, Bagge U, Risberg B. (1995). Leukocyte margination during hemorrhagic shock correlates to pre-shock margination and is reduced by fucoidin. Shock 3:40-45.
44. Yokota J, Chiao JC, Shires GT. (1992). Oxygen free radicals affect cardiac and skeletal cell membrane potential during hemorrhagic shock in rats. Am J Physiol 262, 1 Pt2:H84-H90.